Secukinumab B
Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.
Product Specifications
CAS Number
1229022-83-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV725121 1.0 µg DNA
FAM204BP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details 622087 60 Pack (15 Label (s) x 4 Sheet)
TIL-1-82C/180F-DIA Pre-printed Indicating Labels
Sign In for Pricing
View Details 